RAQUEL
RIVERA DÍAZ
Profesora asociada de Ciencias de la Salud
Hospital Universitario de Getafe
Getafe, EspañaPublikationen in Zusammenarbeit mit Forschern von Hospital Universitario de Getafe (2)
2022
-
Risankizumab in psoriasis: prior biologics failure does not impact on short-term effectiveness
Expert Opinion on Biological Therapy
2020
-
Real-world effectiveness and safety of apremilast in psoriasis at 52 weeks: a retrospective, observational, multicentre study by the Spanish Psoriasis Group
Journal of the European Academy of Dermatology and Venereology, Vol. 34, Núm. 12, pp. 2821-2829